Compounds > resorufin galactopyranoside
Page last updated: 2024-12-07

resorufin galactopyranoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

resorufin galactopyranoside: fluorogenic substrate for beta-galactosidase activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID125273
SCHEMBL ID16069592
MeSH IDM0158620

Synonyms (22)

Synonym
resorufin beta-d-galactopyranoside
7-(beta-d-galactopyranosyloxy)-3h-phenoxazin-3-one
resorufin beta-d-galactopyranoside, ~95%
7-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenoxazin-3-one
AKOS015916747
95079-19-9
3h-phenoxazin-3-one, 7-(beta-d-galactopyranosyloxy)-
resorufin galactopyranoside
resorufin |a-d-galactopyranoside
3h-phenoxazin-3-one,7-(b-d-galactopyranosyloxy)-
mfcd00064055
SCHEMBL16069592
resorufin-i(2)-d-galactopyranoside
DTXSID30241747
7-(((2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-3h-phenoxazin-3-one
7-((2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-3h-phenoxazin-3-one
resorufin beta -d-galactopyranoside
res-gal
STARBLD0016675
CS-0137345
resorufin-|a-d-galactopyranoside
HY-137249

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" By means of the dose-response curve of PN of a hops' remainder extract, the estradiol equivalent concentration (EEQ) and thus the estradiol equivalent amount (EEA) of PN in the hops' remainder after simulation of the wort boiling was determined to 39 μg/L and 52 μg/kg, respectively."( Detection of estrogen active compounds in hops by planar yeast estrogen screen.
Schick, D; Schwack, W, 2018)		0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (8.33)18.7374
1990's1 (8.33)18.2507
2000's4 (33.33)29.6817
2010's6 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.06 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
coumarin
2H-chromen-2-one: coumarin derivative		2.1110coumarinsfluorescent dye;
human metabolite;
plant metabolite
ethinyl estradiol
Ethinyl Estradiol: A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.. 17alpha-ethynylestradiol : A 3-hydroxy steroid that is estradiol substituted by a ethynyl group at position 17. It is a xenoestrogen synthesized from estradiol and has been shown to exhibit high estrogenic potency on oral administration.		2.151017-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound		xenoestrogen
resorufin
[no description available]		2.3920phenoxazine
hydrolapachol
hydrolapachol: inhibits mitochondrial respiratory chain		2.0410
glycosides
[no description available]		1.9710
naphthoquinones
Naphthoquinones: Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.		2.0410
warfarin
Warfarin: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.. warfarin : A racemate comprising equal amounts of (R)- and (S)-warfarin. Extensively used as both an anticoagulant drug and as a pesticide against rats and mice.. 4-hydroxy-3-(3-oxo-1-phenylbutyl)-1-benzopyran-2-one : A member of the class of coumarins that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenyl-3-oxo-1-butyl group.		2.1110benzenes;
hydroxycoumarin;
methyl ketone
ConditionIndicatedRelationship StrengthStudiesTrials
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)		0210